By Josh Beckerman Phio Pharmaceuticals shares rose 60% after the company reported favorable data from two preclinical studies of cancer drug PH-894. The…
Markets – MarketWatch
Phio Pharmaceuticals Shares Up 60% on Favorable PH-894 Preclinical Data Markets – MarketWatch
